Company Information

POLAR PHARMA INDIA LTD.

NSE : NABSE : 523333ISIN CODE : INE145D01019Industry : Rubber ProductsHouse : Polar
BSE0.820 (0 %)
PREV CLOSE ( ) 0.82
OPEN PRICE ( ) 0.82
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 540
TODAY'S LOW / HIGH ( )0.82 0.82
52 WK LOW / HIGH ( ) 0.820.82
NSE
This Company is not listed in NSE
ChairmanAnil Agarwal
Managing DirectorAnil Agarwal
Company SecretaryRupa Gupta
Vice ChairmanSunil Agarwal
Non Executive DirectorMadhu S Mishra
Ved Prakash Jain
Additional DirectorKishan Lal Sharma
Incorporation Year : 1988

Registered Office :

Address : Plot No - 3,Somnathpur Industrial Estate,P O Remuna Balasore Dist,
Orissa-756019 .

Phone : 06782- 224207 224208

Email :  mktpolar@polarinc.com 

Industry : Rubber Products

Listing : BSE,Kolkata

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.